Dr. Georg Lautscham
Dr. Georg Lautscham is CEO at Protagen AG. He joined Protagen in 2013, as he felt that patients suffering from cancer and autoimmune diseases should receive treatments that are both safe and effective. A chemist and immunologist by training, Georg previously led interdisciplinary teams both in Europe and the US, and has years of experience as a biotech executive, with a strong commercial track record in business development, marketing and sales.
Protagen is dedicated to the development of powerful diagnostic tools that aid successful therapeutic development and facilitate improved treatment strategies in the areas of autoimmune disease and immuno-oncology.